Paracoccidioidomycosis classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Paracoccidioidomycosis may be classified according to Franco et al. in 1987 into: paracoccidioidomycosis infection, paracoccidioidomycosis disease, paracoccidioidomycosis associated with inmunosupression and residual form (sequela). Based on the duration of symptoms, paracoccidioidomycosis disease may be classified into: acute, subacute or chronic. The chronic form can be subclassified into: unifocal and multifocal.<ref name="pmid26635779">{{cite journal| author=de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F et al.| title=Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis. | journal=Front Microbiol | year= 2015 | volume= 6 | issue=  | pages= 1319 | pmid=26635779 | doi=10.3389/fmicb.2015.01319 | pmc=PMC4658449 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26635779  }} </ref><ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
Paracoccidioidomycosis may be classified according to Franco et al. in 1987 into: paracoccidioidomycosis [[infection]], paracoccidioidomycosis disease, paracoccidioidomycosis associated with [[immunosupression]] and residual form ([[sequela]]). Based on the duration of symptoms, paracoccidioidomycosis disease may be classified into: [[Acute (medical)|acute]], [[subacute]] or [[Chronic (medical)|chronic]]. The chronic form can be subclassified into: unifocal and multifocal.<ref name="pmid26635779">{{cite journal| author=de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F et al.| title=Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis. | journal=Front Microbiol | year= 2015 | volume= 6 | issue=  | pages= 1319 | pmid=26635779 | doi=10.3389/fmicb.2015.01319 | pmc=PMC4658449 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26635779  }} </ref><ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>


==Classification==
==Classification==
*Paracoccidioidomycosis infection: Patients have no clinical manifestations. Positive reaction to the paracoccidioidin skin test. <ref name=eee>Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
*Paracoccidioidomycosis infection: Patients have no clinical manifestations. Positive reaction to the paracoccidioidin skin test. <ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
*Paracoccidioidomycosis disease
*Paracoccidioidomycosis disease
**Acute form: Usually affects patients under 35 years. <ref name=eee>Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
**[[Acute (medical)|Acute]] form: Usually affects patients under 35 years. <ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
***Moderate
***Moderate
***Severe
***Severe
**Chronic form
**[[Chronic (medical)|Chronic]] form
***Unifocal: Affects one organ or system. <ref name=eee>Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
***Unifocal: Affects one organ or system. <ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
****Mild
****Mild
****Moderate
****Moderate
****Severe
****Severe
***Multifocal: Affects two or more organs or systems. <ref name=eee>Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
***Multifocal: Affects two or more organs or systems. <ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref>
****Mild
****Mild
****Moderate
****Moderate
****Severe
****Severe
*Paracoccidioidomycosis associated with immunosupresion
*Paracoccidioidomycosis associated with [[Immunodeficiency|immunosupression]]
*Residual form (Sequela): Most frequently, pulmonary chronic obstructive disease. <ref name=eee>Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref><ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
*Residual form ([[Sequela]]): Most frequently, [[Chronic obstructive pulmonary disease|chronic pulmonary obstructive disease]]. <ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref><ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>


==References==
==References==

Revision as of 21:07, 21 January 2016

Paracoccidioidomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paracoccidioidomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Paracoccidioidomycosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paracoccidioidomycosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paracoccidioidomycosis classification

CDC on Paracoccidioidomycosis classification

Paracoccidioidomycosis classification in the news

Blogs on Paracoccidioidomycosis classification

Directions to Hospitals Treating Paracoccidioidomycosis

Risk calculators and risk factors for Paracoccidioidomycosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac

Overview

Paracoccidioidomycosis may be classified according to Franco et al. in 1987 into: paracoccidioidomycosis infection, paracoccidioidomycosis disease, paracoccidioidomycosis associated with immunosupression and residual form (sequela). Based on the duration of symptoms, paracoccidioidomycosis disease may be classified into: acute, subacute or chronic. The chronic form can be subclassified into: unifocal and multifocal.[1][2]

Classification

  • Paracoccidioidomycosis infection: Patients have no clinical manifestations. Positive reaction to the paracoccidioidin skin test. [3]
  • Paracoccidioidomycosis disease
    • Acute form: Usually affects patients under 35 years. [3]
      • Moderate
      • Severe
    • Chronic form
      • Unifocal: Affects one organ or system. [3]
        • Mild
        • Moderate
        • Severe
      • Multifocal: Affects two or more organs or systems. [3]
        • Mild
        • Moderate
        • Severe
  • Paracoccidioidomycosis associated with immunosupression
  • Residual form (Sequela): Most frequently, chronic pulmonary obstructive disease. [3][2]

References

  1. ↑ de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F; et al. (2015). "Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis". Front Microbiol. 6: 1319. doi:10.3389/fmicb.2015.01319. PMC 4658449. PMID 26635779.
  2. ↑ 2.0 2.1 Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.
  3. ↑ 3.0 3.1 3.2 3.3 3.4 Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. An. Bras. Dermatol.2013;88(5):700-711
Retrieved from "https://www.wikidoc.org/index.php?title=Paracoccidioidomycosis_classification&oldid=1205129"